Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

PowerPoint Presentation Key TakeawaysContext: MACRA Repealed the SGR Formula No “doc fix” in 2015 would have meant a 21% cut in payments to physicians. Medicare Access and CHIP Reauthorization Act (MACRA) repealed the SGR formula and replaced it with the Quality Payment Program (QPP) • MACRA changed the way in which physicians are reimbursed under Medicare for physician services …
RCC is among the 10 most common cancers in both men and women, with 15-25% of patients having metastatic renal cell carcinoma (mRCC) where the cancer has spread to other parts of the body.[1] Risk factors include: Smoking, body weight/obesity, family history, high blood pressure.[2] Around 20% to 25% of patients diagnosed have already reached the metastatic phase of disease. Once renal cell …
[PODCAST] Pharmacy Benefit Managers: How Advocacy Led to Action Published June 20, 2022 The Federal Trade Commission unanimously launched a formal inquiry into the business practices of the prescription drug middleman industry—known as pharmacy benefit managers (PBMs)—in early June 2022 due to the overwhelming response of more than 24,000 public comments during their request for information. Matt …
Trainee/ Faculty Networking Reception Residents and Fellows from: Amplifying the ADC Advantage: How to Fulfill the Potential of Antibody-Drug Conjugates as the Next Frontier in Precision Lung Cancer Care Melissa L. Johnson, MD Sarah Cannon Research Institute Dinner provided. Accreditation, Support, and Credit In support of improving patient care, PVI, PeerView Institute for Medical …
tools 84 OI | Vol. 39, No. 1, 2024 | accc-cancer.org fulvestrant for adult patients with hormone receptor-positive (HR+)/HER2–, locally advanced or metastatic breast cancer with 1 or more PIK3CA/AKT1/PTEN-alterations as detected by an FDA-approved test following progression on at least 1 endocrine-based regimen in the metastatic setting or recurrence on or within 12 months of completing …
Support HB 1624 to Protect Parenthood After Cancer Give young adult Hawaiian cancer patients hope by providing access to treatments that will protect their ability to have biological children in the future. The National Cancer Institute estimates 334 Adolescent and Young Adult Hawaiians between the ages of 15- 39 will be diagnosed with cancer this year. The Need Some …
A spotlight of Kelsey-Seybold Clinic Cancer Center in Houston, Texas.
Hear the most up-to-date best practices, including shared decision-making, regarding treating patients with CLL in this post-COVID era.
To improve quality of care and quality of life for patients with myelofibrosis, the Association of Community Cancer Centers (ACCC) has developed an initiative titled, Advancements in Treating Patients with Myelofibrosis and Strategies to Improve Care.
MJ06-Leksell-Gamma-Knife
Leksell-Gamma-Knife-MJ06
Enhancing Equity in Clinical Research: Lessons from Community Oncology Engagement Efforts Tennessee Oncology Practice Society Annual Meeting 14 May 2022 Dr. Richard Lewis Martin III, MD, MPH (he/him/his) Meharry Medical College Disclosures • None • Funding U54 CA0914010 (NCI) 09/01/2021-08/31/2025 Meharry-Vanderbilt-TSU Cancer Partnership Disclaimer …
Enhancing Equity in Clinical Research: Lessons from Community Oncology Engagement Efforts South Carolina Oncology Society Annual Meeting 6 August 2022 Dr. Richard Lewis Martin III, MD, MPH (he/him/his) Tennessee Oncology Disclosure of Conflicts of Interest • Funding • U54 CA0914010 (NCI) • 09/01/2021-08/31/2025 • Meharry-Vanderbilt-TSU Cancer Partnership • …
ND15-Tools
ACCC's Patient Advocacy Meeting and 3rd Annual Oncology Presidents' Institute : .' • ACCC AcnoN • ACCC's Patient Advocacy Meeting and 3rd Annual Oncology Presidents' Institute A IUSY SCNEDUIL •.-ITE THE SEPlDISER TRAGEDY Members of ACCC's Board of Trusteesand staffof the Association of Community Cancer Centers extended their condolences to all thosewho suffered the tragedy of …
New Products Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 New Products To cite this article: (2000) New Products, Oncology Issues, 15:1, 11-12, DOI: 10.1080/10463356.2000.11905100 …
tools 12 accc-cancer.org | September–October 2017 | OI Approved Drugs • The Food and Drug Administration (FDA) has approved Pfizer’s (Pfizer.com) Besponsa® (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lympho- blastic leukemia (ALL). • Amgen (amgen.com) announced that the FDA has approved the supplemental biologics …
MA05-Analyzing-Your-Radiation-Service
33(4)_Final-corrected 7-19.indd tools Approved Drugs • Helsinn (helsinn.com) announced that the U.S. Food and Drug Administration (FDA) has approved the intravenous formulation of Akynzeo® (netupitant/ palonosetron) for patients experiencing chemotherapy- induced nausea and vomiting. The FDA has approved Akynzeo IV in combination with dexamethasone in adults for the prevention …